E2F8 and skin neoplasm: In contrast, E2F8 deficient skin tumors displayed enhanced angiogenesis, and E2F8 inhibited tumor angiogenesis in a xenograft model for sarcomas driven by Myc and Ras oncogenes and suppressed intratumoral vessel hyperbranching via induction of delta-like ligand 4 [7].